Shernaz Walton

2.2k total citations
52 papers, 947 citations indexed

About

Shernaz Walton is a scholar working on Dermatology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Shernaz Walton has authored 52 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Dermatology, 14 papers in Epidemiology and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Shernaz Walton's work include Autoimmune Bullous Skin Diseases (13 papers), Dermatology and Skin Diseases (9 papers) and Psoriasis: Treatment and Pathogenesis (7 papers). Shernaz Walton is often cited by papers focused on Autoimmune Bullous Skin Diseases (13 papers), Dermatology and Skin Diseases (9 papers) and Psoriasis: Treatment and Pathogenesis (7 papers). Shernaz Walton collaborates with scholars based in United Kingdom, Germany and United States. Shernaz Walton's co-authors include K. Keczkes, E.H. Wyatt, Henry Bury, John Bennett, Cynthia L. Nicholson, Anthony D. Ormerod, Hywel C Williams, W.J. Cunliffe, James Mason and Nicola Greenlaw and has published in prestigious journals such as Gut, Cochrane Database of Systematic Reviews and BMJ.

In The Last Decade

Shernaz Walton

46 papers receiving 901 citations

Peers

Countries citing papers authored by Shernaz Walton

Since Specialization

Citations

This map shows the geographic impact of Shernaz Walton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shernaz Walton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shernaz Walton more than expected).

Fields of papers citing papers by Shernaz Walton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shernaz Walton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shernaz Walton. The network helps show where Shernaz Walton may publish in the future.

Co-authorship network of co-authors of Shernaz Walton

This figure shows the co-authorship network connecting the top 25 collaborators of Shernaz Walton. A scholar is included among the top collaborators of Shernaz Walton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shernaz Walton. Shernaz Walton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk of suicide and suicidality in patients with moderate to severe psoriasis: results from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) 2024 ·Clinical and Experimental Dermatology ·K. Williams, (unknown), Nick J. Reynolds, Kathleen McElhone, Ian M. Evans, Richard B. Warren, Shernaz Walton, (unknown), Anthony Bewley, K.J. Mason, C. Elise Kleyn	2
2	Attentional bias in psoriasis: The role of processing time and emotional valence 2023 ·British Journal of Health Psychology ·(unknown), David N. George, Antoinette I. M. van Laarhoven, C. Elise Kleyn, Shernaz Walton, Henning Holle	0
3	Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register ( BADBIR ) 2018 ·British Journal of Dermatology ·Zenas Z N Yiu, Darren M. Ashcroft, Ian Evans, Kathleen McElhone, Mark Lunt, Catherine Smith, Shernaz Walton, Ruth Murphy, Nick J. Reynolds, Anthony D. Ormerod, C.E.M. Griffiths, Richard B. Warren, (unknown)	26
4	Risk of Serious Infection in Patients with Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR) 2017 ·Journal of Investigative Dermatology ·Zenas Z N Yiu, Catherine Smith, Darren M. Ashcroft, Mark Lunt, Shernaz Walton, Ruth Murphy, Nick J. Reynolds, Anthony D. Ormerod, C.E.M. Griffiths, Richard B. Warren	49
5	Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial 2015 ·BMJ ·Anthony D. Ormerod, Kim S Thomas, Fiona E. Craig, Eleanor Mitchell, Nicola Greenlaw, John Norrie, James Mason, Shernaz Walton, G.A. Johnston, Hywel C Williams	152
6	Diabetic dermopathy 2014 ·The British Journal of Diabetes ·Susannah George, Shernaz Walton	10
7	An examination of the comparative ability of primary care health professionals in the recognition and treatment of a range of dermatological conditions 2013 ·University of Huddersfield Repository (University of Huddersfield) ·(unknown), Mihir Patel, (unknown), Shernaz Walton	4
8	Current application of National Institute for Health and Clinical Excellence (NICE) guidance in the management of patients with severe psoriasis: a clinical audit against NICE guidance in seven National Health Service specialist dermatology units in Engla 2011 ·Clinical and Experimental Dermatology ·Anthony Bewley, R. Cerio, (unknown), (unknown), T. Lücke, R. Ratnavel, Shernaz Walton, (unknown)	6
9	A case of sarcoidosis occurring within an extensive burns scar 2006 ·Journal of Plastic Reconstructive & Aesthetic Surgery ·(unknown), Shamim Akhtar, (unknown), (unknown), Shernaz Walton	3
10	Clinical, ultrasound and hormonal markers of androgenicity in acne vulgaris 1995 ·British Journal of Dermatology ·Shernaz Walton, W.J. Cunliffe, K. Keczkes, (unknown), H H McGarrigle, M. Katz, (unknown)	52
11	Patch test audit: are we doing more than we need to? 1994 ·Contact Dermatitis ·(unknown), Shernaz Walton	3
12	The emerging epidemic of skin cancer 1994 ·British Journal of Dermatology ·(unknown), Shernaz Walton, K. Keczkes, Henry Bury, Cynthia L. Nicholson	111
13	PYODERMA GANGRENOSUM: ASSOCIATIONS REVISITED 1992 ·International Journal of Dermatology ·(unknown), Shernaz Walton, E.H. Wyatt	33
14	Extensive and fatal basal cell carcinoma: a report of three cases 1992 ·British Journal of Dermatology ·(unknown), Shernaz Walton, K. Keczkes	46
15	Esophageal involvement in Geh�et's Disease 1992 ·Digestive Diseases and Sciences ·W.W. Bottomley, (unknown), Shernaz Walton, John Bennett	20
16	Skin and gullet. 1991 ·Gut ·Shernaz Walton, John Bennett	7
17	Pseudo T-cell lymphoma due to scabies in a patient with Hodgkin's disease 1991 ·British Journal of Dermatology ·Shernaz Walton, W.W. Bottomley, E.H. Wyatt, Henry Bury	12
18	Rosacea and Ulcerative Colitis 1990 ·Journal of Clinical Gastroenterology ·Shernaz Walton, (unknown), E.H. Wyatt	11
19	The oesophagus in lichen planus: an endoscopic study. 1990 ·BMJ ·Chris Dickens, D. Heseltine, Shernaz Walton, John Bennett	60
20	Variation in Mast Cell Numbers in Psoriasis and Lichen planus: Comparisons with Normal Skin 1983 ·Dermatology ·Shernaz Walton, (unknown)	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact